Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

Aug, 2017   |   42  Pages   |   GlobalData   |   Format : PDF

Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With sales offices in India, the US, the UK, China and Colombia, the company offers products and solutions to companies across the world. Granules have sales offices located in India, the US, the UK, China and Colombia. The company has three facilities in Hyderabad, India; one facility in Visakhapatnam, India; and one facility in Jingmen, China. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Ltd Key Recent Developments

Aug 16,2017: Granules India Reports Establishment Inspection Report (EIR) From US FDA-Reg.
Aug 14,2017: Granules India Reported Its First Quarter Financial Results 2017
Jun 08,2017: Pharmaceutical company to expand in Virginia
Feb 03,2017: Granules India's Gagillapur facility completed INFARMED reinspection
Jan 06,2017: Granules India's Gagillapur Facility Completed INFARMED Inspection

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Granules India Ltd - Key Facts 5
Granules India Ltd - Key Employees 6
Granules India Ltd - Key Employee Biographies 7
Granules India Ltd - Major Products and Services 8
Granules India Ltd - History 9
Granules India Ltd - Company Statement 10
Granules India Ltd - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Joint Venture 11
Section 2 - Company Analysis 12
Granules India Ltd - Business Description 12
Granules India Ltd - SWOT Analysis 13
SWOT Analysis - Overview 13
Granules India Ltd - Strengths 13
Granules India Ltd - Weaknesses 14
Granules India Ltd - Opportunities 15
Granules India Ltd - Threats 16
Granules India Ltd - Key Competitors 17
Section 3 - Company Financial Ratios 18
Financial Ratios - Capital Market Ratios 18
Financial Ratios - Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 - Company's Lifesciences Financial Deals and Alliances 25
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Granules India Ltd, Recent Deals Summary 27
Section 5 - Company's Recent Developments 28
Aug 16, 2017: Granules India Reports Establishment Inspection Report (EIR) From US FDA-Reg. 28
Aug 14, 2017: Granules India Reported Its First Quarter Financial Results 2017 29
Feb 03, 2017: Granules India's Gagillapur facility completed INFARMED reinspection 30
Jan 06, 2017: Granules India's Gagillapur Facility Completed INFARMED Inspection 31
Jan 04, 2017: Granules India Announces Appointment of Dr. V.V.N.K.V. Prasada Raju as an Additional Director 32
Dec 19, 2016: Granules India Provides Update On Granules OmniChem Facility 33
Oct 17, 2016: Granules India's Gagillapur facility successfully completed US FDA inspection 34
May 30, 2016: Granules India's Jeedimetla plant received Establishment Inspection Report from the US FDA 35
Apr 28, 2016: Granules India : Revenue increases 11% to Rs. 1,431 Cr.; Net Profit surges 30% to Rs. 118 Cr 36
Jan 28, 2016: Granules India : Revenue increases 8% to Rs. 345 Cr.; Net Profit surges 15% to Rs. 27 Cr 37
Section 6 - Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Granules India Ltd, Key Facts 5
Granules India Ltd, Key Employees 6
Granules India Ltd, Key Employee Biographies 7
Granules India Ltd, Major Products and Services 8
Granules India Ltd, History 9
Granules India Ltd, Subsidiaries 11
Granules India Ltd, Joint Venture 11
Granules India Ltd, Key Competitors 17
Granules India Ltd, Ratios based on current share price 18
Granules India Ltd, Annual Ratios 19
Granules India Ltd, Annual Ratios (Cont...1) 20
Granules India Ltd, Annual Ratios (Cont...2) 21
Granules India Ltd, Interim Ratios 23
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Granules India Ltd, Recent Deals Summary 27
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List of Figures
Granules India Ltd, Performance Chart (2013 - 2017) 22
Granules India Ltd, Ratio Charts 24
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Granules India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Fax Number: +91 22 27812707

Follow Us On: